Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KAT2B | Q92831 | 1/20 | 0.70 |
| ▸ | RAB9A | P51151 | 3/20 | 0.61 |
| ▸ | MAPT | P10636 | 7/20 | 0.61 |
| ▸ | PKM | P14618 | 2/20 | 0.61 |
| ▸ | LMNA | P02545 | 1/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.58 |
| ▸ | TSHR | P16473 | 1/20 | 0.58 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.58 |
| ▸ | VCAM1 | P19320 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.51 |
| ▸ | PRSS1 | P07477 | 3/20 | 0.46 |
| ▸ | HCAR3 | P49019 | 1/20 | 0.46 |
| ▸ | MERTK | Q12866 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29519350 | 1.00 | KAT2B (0.70) | KAT2BRAB9AMAPTPKMLMNA | |
| SCHEMBL6218547 | 0.92 | KAT2B (0.74) | KAT2BRAB9AMAPTPKMLMNA | |
| SCHEMBL6214461 | 0.91 | KAT2B (0.73) | KAT2BRAB9AMAPTPKMLMNA | |
| SCHEMBL6220073 | 0.89 | KAT2B (0.71) | KAT2BRAB9AMAPTPKMLMNA | |
| SCHEMBL7371227 | 0.89 | RAB9A (0.61) | KAT2BRAB9AMAPTPKMLMNA | |
| SCHEMBL9516451 | 0.87 | KAT2B (0.61) | KAT2BRAB9AMAPTPKMLMNA | |
| SCHEMBL1204829 | 0.86 | KAT2B (0.70) | KAT2BRAB9AMAPTPKMLMNA | |
| SCHEMBL31069460 | 0.86 | KAT2B (0.70) | KAT2BRAB9AMAPTPKMLMNA | |
| SCHEMBL11544206 | 0.85 | KAT2B (0.65) | KAT2BRAB9AMAPTPKMLMNA | |
| SCHEMBL29519405 | 0.83 | KAT2B (0.73) | KAT2BMAPTPKMLMNAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 488 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5972044-A | Composition and method for dyeing keratin fibers | WELLA AG (DE) | 1999-10-26 | — | — | US | claimed |
| EP-0867170-A2 | Composition and method for dyeing keratin fibres | Wella Aktiengesellschaft (DE) | 1998-09-30 | — | — | EP | claimed |
| EP-0391662-B1 | Nitroaniline dyes with a cyano substituent group | BRISTOL MYERS SQUIBB CO (US) | 1993-10-27 | — | — | EP | claimed |
| US-5024673-A | Colorfast direct yellow hair dye | CLAIROL INCORPORATED (US) | 1991-06-18 | — | — | US | claimed |
| EP-0391662-A1 | Nitroaniline dyes with a cyano substituent group | Bristol-Myers Squibb Company (US) | 1990-10-10 | — | — | EP | claimed |
| JP-2268147-A | — | — | None | — | — | JP | disclosed |
| US-20250326764-A1 | INHIBITORS OF THE MENIN-MLL INTERACTION | VITAE PHARMACEUTICALS LLC (US) | 2025-10-23 | — | — | US | disclosed |
| US-12312359-B2 | Inhibitors of the menin-MLL interaction | VITAE PHARMACEUTICALS, LLC (US) | 2025-05-27 | — | — | US | disclosed |
| CN-118359610-A | MENIN-MLL interaction inhibitors | 生命医药有限责任公司 | 2024-07-19 | — | — | CN | disclosed |
| US-20240124447-A1 | INHIBITORS OF THE MENIN-MLL INTERACTION | VITAE PHARMACEUTICALS, LLC (US) | 2024-04-18 | — | — | US | disclosed |
| US-11739085-B2 | Inhibitors of the menin-MLL interaction | VITAE PHARMACEUTICALS, LLC (US) | 2023-08-29 | — | — | US | disclosed |
| US-11739085-B2 | Inhibitors of the menin-MLL interaction | VITAE PHARMACEUTICALS, LLC (US) | 2023-08-29 | — | — | US | disclosed |
| WO-1998011863-A2 | HAIR DYE | WELLA AKTIENGESELLSCHAFT (DE) | 1998-03-26 | — | — | WO | disclosed |
| EP-0821935-A2 | Composition for dyeing and tinting hair | Wella Aktiengesellschaft (DE) | 1998-02-04 | — | — | EP | disclosed |
| EP-0806199-A2 | Composition and method for dyeing keratin fibres | Wella Aktiengesellschaft (DE) | 1997-11-12 | — | — | EP | disclosed |
| EP-0391662-B1 | Nitroaniline dyes with a cyano substituent group | BRISTOL MYERS SQUIBB CO (US) | 1993-10-27 | — | — | EP | disclosed |
| US-5024673-A | Colorfast direct yellow hair dye | CLAIROL INCORPORATED (US) | 1991-06-18 | — | — | US | disclosed |
| US-4980158-A | HAIR DYES; PHOTOSTABILITY, WASHFASTNESS | CLAIROL INCORPORATED (US) | 1990-12-25 | — | — | US | disclosed |
| JP-H02268147-A | NITROANILINE DYE WITH CYANO SUBSTITUENT | BRISTOL MYERS SQUIBB CO | 1990-11-01 | — | — | JP | disclosed |
| EP-0391662-A1 | Nitroaniline dyes with a cyano substituent group | Bristol-Myers Squibb Company (US) | 1990-10-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12312359-B2 | Inhibitors of the menin-MLL interaction | MLLT1, MEN1, MLLT3 | KAT2B 405/4885RAB9A 2372/4885MAPT 1447/4885 |
| US-11739085-B2 | Inhibitors of the menin-MLL interaction | MLLT1, MEN1, MLLT3 | KAT2B 405/4885RAB9A 2372/4885MAPT 1447/4885 |
| US-20240124447-A1 | INHIBITORS OF THE MENIN-MLL INTERACTION | MLLT1, MEN1, MLLT3 | KAT2B 405/4885RAB9A 2372/4885MAPT 1447/4885 |
| US-20250326764-A1 | INHIBITORS OF THE MENIN-MLL INTERACTION | MLLT1, MEN1, MLLT3 | KAT2B 405/4885RAB9A 2372/4885MAPT 1447/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.